Front Row Advisors’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-66
Closed -$8.79K 636
2023
Q3
$8.79K Sell
66
-4
-6% -$658 ﹤0.01% 550
2023
Q2
$13K Hold
70
0.01% 460
2023
Q1
$16K Hold
70
0.01% 418
2022
Q4
$14K Buy
70
+36
+106% +$7.46K 0.01% 434
2022
Q3
$6K Sell
34
-2
-6% -$396 ﹤0.01% 610
2022
Q2
$6K Hold
36
﹤0.01% 626
2022
Q1
$12K Hold
36
﹤0.01% 520
2021
Q4
$13K Hold
36
﹤0.01% 515
2021
Q3
$14K Sell
36
-1
-3% -$460 0.01% 491
2021
Q2
$17K Hold
37
0.01% 456
2021
Q1
$14K Buy
37
+4
+12% +$1.63K 0.01% 478
2020
Q4
$12K Hold
33
0.01% 475
2020
Q3
$10K Buy
+33
New +$11.4K 0.01% 509

Other funds holding ILMN

Front Row Advisors's ILMN Position: Q4 2023 in Review

Front Row Advisors sold out of Illumina (ILMN) in Q4 2023, closing a stake of 66 shares — an estimated $8.79K sold.

Front Row Advisors first reported a position in ILMN in Q3 2020 and held it in 13 quarters. The position peaked at $17K in Q2 2021. 810 funds tracked by Wall St. Rank hold ILMN as of Q4 2023.

  • Front Row Advisors reported no remaining Illumina position as of Q4 2023 after selling out during the quarter.
  • Front Row Advisors sold 66 Illumina shares in Q4 2023, an estimated $8.79K.
  • Front Row Advisors first reported a position in Illumina in Q3 2020 and held it in 13 quarters.
  • Front Row Advisors's Illumina position peaked at $17K in Q2 2021.
  • 810 funds tracked by Wall St. Rank held Illumina as of Q4 2023.

Based on Front Row Advisors's 13F filing for Q4 2023, filed 15 Feb 2024.